Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,294.50 -12.67 -0.08%
S&P 500 1,650.51 -4.84 -0.29%
Nasdaq 3,459.42 -3.88 -0.11%
Ticker Volume Price Price Delta
STOXX 50 2,776.78 -58.23 -2.05%
FTSE 100 6,696.79 -143.48 -2.10%
DAX 8,351.98 -178.91 -2.10%
Ticker Volume Price Price Delta
Nikkei 14,484.00 -1,143.28 -7.32%
Hang Seng 22,669.70 -591.40 -2.54%
S&P/ASX 200 5,070.90 +8.45 0.17%
BREAKING NEWS
Google Said to Consider Buying Waze Presaging Possible Bid War

Hamptons Scene: Harvard Researcher Eggan Courts Patricof, Wien

Harvard scientist Kevin Eggan started Friday in Bar Harbor, Maine, speaking at the Jackson Laboratory, the U.S.’s largest repository of mutant mice.

Two commercial-plane rides and one long drive later, he was at a cocktail party in East Hampton, New York, benefiting the New York Stem Cell Foundation.

Eggan, associate professor of stem cell and regenerative biology at Harvard University, is chief scientific officer of the New York Stem Cell Foundation.

This year the foundation will spend $18 million -- a $6.4 million increase over last year -- on stem cell and neuroscience research, including grants to early-career investigators.

“This is disruptive medical research, like the discovery of penicillin,” said Eggan, standing near a row of blue hydrangea bushes at the home of Jodie and John Eastman on Lily Pond Lane.

The red-haired 2006 MacArthur Fellow is developing a stem cell bank that will allow drugs to be tested in the laboratory.

“It’s a clinical trial in a dish,” he said. “We can see better which people respond to which drugs before putting them in humans.”

Campari-and-Soda

Eggan nursed a Campari-and-soda while he chatted with guests including Byron Wien, vice chairman of Blackstone Advisory Partners LP; Alan Patricof, managing director and founder of Greycroft Partners LLC; Jonathan Schulhof, managing director of GTI Capital Group LLC; and Peter J. Solomon, chairman and founder of Peter J. Solomon Co.

“The amount of time I spend at an event like this is a fraction of the time I spend writing a grant,” Eggan said. “Not only that, the money that results is more flexible and makes us more nimble.”

Accountability is another plus. “People like Stanley and Fiona Druckenmiller and Julian Robertson, they demand results because they’re used to getting them. I love that,” Eggan said.

Robertson, founder of Tiger Management LLC, gave $27 million to the foundation to fund early-career investigators. The foundation will honor him at a fundraising dinner on Oct. 11 in New York.

(Amanda Gordon is a writer and photographer for Muse, the arts and leisure section of Bloomberg News. Any opinions expressed are her own.)

To contact the writer on this story: Amanda Gordon in New York at agordon01@bloomberg.net or on Twitter at @amandagordon.

To contact the editor responsible for this story: Manuela Hoelterhoff at mhoelterhoff@bloomberg.net.

Enlarge image New York Stem Cell Foundation

New York Stem Cell Foundation

New York Stem Cell Foundation

Amanda Gordon/Bloomberg

John Eastman welcomes guests to a New York Stem Cell Foundation fundraising party at his home in East Hampton, New York.

John Eastman welcomes guests to a New York Stem Cell Foundation fundraising party at his home in East Hampton, New York. Photographer: Amanda Gordon/Bloomberg

Enlarge image New York Stem Cell Foundation

New York Stem Cell Foundation

New York Stem Cell Foundation

Amanda Gordon/Bloomberg

Kevin Eggan, chief scientific officer of the New York Stem Cell Foundation, with Jodie Eastman and Marlene Hess.

Kevin Eggan, chief scientific officer of the New York Stem Cell Foundation, with Jodie Eastman and Marlene Hess. Photographer: Amanda Gordon/Bloomberg

Enlarge image New York Stem Cell Foundation

New York Stem Cell Foundation

New York Stem Cell Foundation

Amanda Gordon/Bloomberg

Alan Patricof, managing director and founder, Greycroft Partners LLC, with Jonathan Schulhof, managing director, GTI Capital Group LLC, and Kimberly Schulhof.

Alan Patricof, managing director and founder, Greycroft Partners LLC, with Jonathan Schulhof, managing director, GTI Capital Group LLC, and Kimberly Schulhof. Photographer: Amanda Gordon/Bloomberg

Enlarge image New York Stem Cell Foundation

New York Stem Cell Foundation

New York Stem Cell Foundation

Amanda Gordon/Bloomberg

Richard Oldenburg, director emeritus, Museum of Modern Art, and Byron Wien, vice chairman, Blackstone Advisory Partners LP.

Richard Oldenburg, director emeritus, Museum of Modern Art, and Byron Wien, vice chairman, Blackstone Advisory Partners LP. Photographer: Amanda Gordon/Bloomberg

Enlarge image New York Stem Cell Foundation

New York Stem Cell Foundation

New York Stem Cell Foundation

Amanda Gordon/Bloomberg

Aiqun Li, staff scientist at the New York Stem Cell Foundation, presents his research (on a party-friendly iPad) to Sandy and Steve Abramson.

Aiqun Li, staff scientist at the New York Stem Cell Foundation, presents his research (on a party-friendly iPad) to Sandy and Steve Abramson. Photographer: Amanda Gordon/Bloomberg

Enlarge image New York Stem Cell Foundation

New York Stem Cell Foundation

New York Stem Cell Foundation

Amanda Gordon/Bloomberg

Architect Robert A.M. Stern, whose current projects include two new residential colleges at Yale and a building at Harvard Law School.

Architect Robert A.M. Stern, whose current projects include two new residential colleges at Yale and a building at Harvard Law School. Photographer: Amanda Gordon/Bloomberg

Enlarge image New York Stem Cell Foundation

New York Stem Cell Foundation

New York Stem Cell Foundation

Amanda Gordon/Bloomberg

Fiona Waterstreet, a retired fashion executive, and Emma Kurz, a pre-med student at Princeton.

Fiona Waterstreet, a retired fashion executive, and Emma Kurz, a pre-med student at Princeton. Photographer: Amanda Gordon/Bloomberg

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.

Sponsored Link